The BIO Investor Forum is back! Join us at the Hilton San Francisco Union Square from October 17-18 for two days of thought-leadership, BIO One-on-One Partnering™ and insight into investment trends and the priorities of venture-stage growth and emerging public biotech companies.
More…
Today, we recap the World Vaccine Congress in Washington, D.C., and look at a recent report highlighting the economic and environmental benefits of biobased products. Enjoy the weekend. (532 words, 2 minutes, 39 seconds)
We’ve made it easier for you to access information and share content about biotechnology and how it improves our daily lives, from prescription medications and a resilient food supply to renewable energy and sustainable bioprocessing materials. The information you discover can easily be shared…
Genome editing represents one of the most promising areas of biotechnology, with the potential to produce transformative breakthroughs in both human health and agriculture. Below you will find important resources and background materials to better understand these groundbreaking innovations and…
Welcome to BIO’s Diversity & Inclusion toolkit—a set of practical tools for developing programs, procedures and best practices to build the right mix for your team. Whether you are just getting started on the journey to a more inclusive work environment or looking to enhance what you…
The Biotechnology Innovation Organization (BIO) is committed to creating a more globally competitive biotechnology industry by promoting and enhancing workforce development, diversity, and inclusion (WDDI). Our published principles inform our WDDI initiatives including the development of resources…
Breaking this morning: BIO President and CEO John F. Crowley writes in STAT News why the U.S. must maintain its leadership in biotechnology (and how). Plus, dengue is spreading—and warmer weather is to blame. (581 words, 2 minutes, 54 seconds)